
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4803640
[patent_doc_number] => 20080015229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'USE OF RIMONABANT FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 11/832865
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2042
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015229.pdf
[firstpage_image] =>[orig_patent_app_number] => 11832865
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/832865 | USE OF RIMONABANT FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES | Aug 1, 2007 | Abandoned |
Array
(
[id] => 5085948
[patent_doc_number] => 20070275999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING A HYPOGLYCEMIC AGENT(S) FOR IMPROVING OR TREATING IMPAIRED GLUCOSE TOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE OR HYPERINSULINEMIA'
[patent_app_type] => utility
[patent_app_number] => 11/831211
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3245
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275999.pdf
[firstpage_image] =>[orig_patent_app_number] => 11831211
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/831211 | PHARMACEUTICAL COMPOSITIONS CONTAINING A HYPOGLYCEMIC AGENT(S) FOR IMPROVING OR TREATING IMPAIRED GLUCOSE TOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE OR HYPERINSULINEMIA | Jul 30, 2007 | Abandoned |
Array
(
[id] => 6249367
[patent_doc_number] => 20100137393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'PREDICTION AND PROPHYLACTIC TREATMENT OF TYPE 1 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/375411
[patent_app_country] => US
[patent_app_date] => 2007-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9203
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137393.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375411 | Prediction and prophylactic treatment of type 1 diabetes | Jul 29, 2007 | Issued |
Array
(
[id] => 4676923
[patent_doc_number] => 20080214554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Methods for preventing or treating cardiac arrhythmia'
[patent_app_type] => utility
[patent_app_number] => 11/878611
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5112
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11878611
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/878611 | Methods for treating cardiac arrhythmia | Jul 24, 2007 | Issued |
Array
(
[id] => 5166104
[patent_doc_number] => 20070287691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'METHOD FOR ACTIVATING THE LIPID CATABOLIC METABOLISM IN ENTERIC EPITHELIUM AND IMPROVING THE LIPID METABOLISM IN ENTERIC EPITHELIUM'
[patent_app_type] => utility
[patent_app_number] => 11/781520
[patent_app_country] => US
[patent_app_date] => 2007-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13245
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287691.pdf
[firstpage_image] =>[orig_patent_app_number] => 11781520
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/781520 | METHOD FOR ACTIVATING THE LIPID CATABOLIC METABOLISM IN ENTERIC EPITHELIUM AND IMPROVING THE LIPID METABOLISM IN ENTERIC EPITHELIUM | Jul 22, 2007 | Abandoned |
Array
(
[id] => 247113
[patent_doc_number] => 07585865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'Protein kinase C zeta inhibition to treat vascular permeability'
[patent_app_type] => utility
[patent_app_number] => 11/781498
[patent_app_country] => US
[patent_app_date] => 2007-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14102
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11781498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/781498 | Protein kinase C zeta inhibition to treat vascular permeability | Jul 22, 2007 | Issued |
Array
(
[id] => 82000
[patent_doc_number] => 07745487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/778237
[patent_app_country] => US
[patent_app_date] => 2007-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2822
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745487.pdf
[firstpage_image] =>[orig_patent_app_number] => 11778237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/778237 | Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions | Jul 15, 2007 | Issued |
Array
(
[id] => 81999
[patent_doc_number] => 07745486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Quercetin-containing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/778234
[patent_app_country] => US
[patent_app_date] => 2007-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3035
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11778234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/778234 | Quercetin-containing compositions | Jul 15, 2007 | Issued |
Array
(
[id] => 4688767
[patent_doc_number] => 20080032948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'NOVEL ANTIFOLATE COMBINATION THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 11/776329
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5637
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11776329
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/776329 | Antifolate combination therapies | Jul 10, 2007 | Issued |
Array
(
[id] => 64014
[patent_doc_number] => 07759334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Soluble forms of amoxicillin and treatment of animals'
[patent_app_type] => utility
[patent_app_number] => 11/769195
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4082
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769195 | Soluble forms of amoxicillin and treatment of animals | Jun 26, 2007 | Issued |
Array
(
[id] => 4823482
[patent_doc_number] => 20080227865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'COLIPSE-LIPASE INHIBITORS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION IN ORDER TO PREVENT OBESITY'
[patent_app_type] => utility
[patent_app_number] => 11/769299
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7329
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769299 | COLIPSE-LIPASE INHIBITORS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION IN ORDER TO PREVENT OBESITY | Jun 26, 2007 | Abandoned |
Array
(
[id] => 4933506
[patent_doc_number] => 20080004281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'METHODS FOR THE MODULATION OF CRP BY THE SELECTIVE MODULATION OF PPAR DELTA'
[patent_app_type] => utility
[patent_app_number] => 11/768887
[patent_app_country] => US
[patent_app_date] => 2007-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14998
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004281.pdf
[firstpage_image] =>[orig_patent_app_number] => 11768887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/768887 | METHODS FOR THE MODULATION OF CRP BY THE SELECTIVE MODULATION OF PPAR DELTA | Jun 25, 2007 | Abandoned |
Array
(
[id] => 5210078
[patent_doc_number] => 20070248662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Utilization of Dialkylfumarates'
[patent_app_type] => utility
[patent_app_number] => 11/765563
[patent_app_country] => US
[patent_app_date] => 2007-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3877
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11765563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/765563 | Utilization of dialkylfumarates | Jun 19, 2007 | Issued |
Array
(
[id] => 5210079
[patent_doc_number] => 20070248663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Utilization of Dialkylfumerates'
[patent_app_type] => utility
[patent_app_number] => 11/765578
[patent_app_country] => US
[patent_app_date] => 2007-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3883
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11765578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/765578 | Utilization of dialkylfumarates | Jun 19, 2007 | Issued |
Array
(
[id] => 8653141
[patent_doc_number] => 08372890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Functional food containing sodium tricaffeoylaldarate'
[patent_app_type] => utility
[patent_app_number] => 12/304803
[patent_app_country] => US
[patent_app_date] => 2007-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9281
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12304803
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/304803 | Functional food containing sodium tricaffeoylaldarate | Jun 17, 2007 | Issued |
Array
(
[id] => 5166098
[patent_doc_number] => 20070287685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Medicinal composition containing FBPase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/818534
[patent_app_country] => US
[patent_app_date] => 2007-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4898
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287685.pdf
[firstpage_image] =>[orig_patent_app_number] => 11818534
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/818534 | Medicinal composition containing FBPase inhibitor | Jun 13, 2007 | Abandoned |
Array
(
[id] => 4797961
[patent_doc_number] => 20080009547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Method for inhibiting or reversing non-enzymatic glycation'
[patent_app_type] => utility
[patent_app_number] => 11/756689
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3249
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009547.pdf
[firstpage_image] =>[orig_patent_app_number] => 11756689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/756689 | Method for inhibiting or reversing non-enzymatic glycation | May 31, 2007 | Issued |
Array
(
[id] => 5011461
[patent_doc_number] => 20070281940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'USES OF DPP-IV INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/744703
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10245
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11744703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/744703 | Uses of DPP-IV inhibitors | May 3, 2007 | Issued |
Array
(
[id] => 4745348
[patent_doc_number] => 20080089950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Methods and compositions for modulating the immune system and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/800420
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 47930
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089950.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800420
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800420 | Methods and compositions for modulating the immune system and uses thereof | May 3, 2007 | Abandoned |
Array
(
[id] => 6599592
[patent_doc_number] => 20100292261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'QUORUM SENSING ANTAGONIST, METHOD OF PREVENTING A BIOFILM FORMATION USING THE QUORUM SENSING ANTAGONIST AND METHOD OF REDUCING A BACTERIAL CONTAMINATION USING THE QUORUM SENSING ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/067731
[patent_app_country] => US
[patent_app_date] => 2007-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6942
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292261.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067731 | Quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist | May 2, 2007 | Issued |